Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuromuscular
At what point do you consider weaning steroids or immuno-modulating agents in patients with Myasthenia Gravis?
How long do you monitor for clinical stability?
Related Questions
Would you recommend muscle or nerve biopsy in a patient with amyoplasia congenita?
What is your approach to the management of Bell's palsy that has not improved after six months?
What nutritional supplements do you recommend for patients with ALS?
How do you initiate steroids in ocular Myasthenia Gravis?
When do you start to cross-titrate from steroids to CellCept in patients with Myasthenia Gravis?
When and how do you deviate from efgartigimod (Vyvgart) dosing from the drug label recommendation of weekly infusions for four weeks in patients with myasthenia gravis?
Would you add immunosuppression in ocular myasthenia gravis patients who are symptomatically well-controlled on pyridostigmine?
When do you test for myasthenia antibodies beyond AChR and MuSK?
Do you utilize phrenic nerve EMG in patients with diaphragmatic issues?
What is your approach to a child with toe walking with a reassuring exam but a family history of difficulty walking?